The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment

The development of cancer causes disruption of anti-tumor immunity required for surveillance and elimination of tumor cells. Immunotherapeutic strategies aim for the restoration or establishment of these anti-tumor immune responses. Cancer immunotherapies include immune checkpoint inhibitors (ICIs),...

Full description

Bibliographic Details
Main Authors: Ifeanyi Kingsley Uche, Konstantin G. Kousoulas, Paul J. F. Rider
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Viruses
Subjects:
herpes
VC2
immunotherapy
oncolytic virus
herpesvirus
HSV
Online Access:https://www.mdpi.com/1999-4915/13/7/1200

Similar Items

Similar Items